Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Bristol Myers Squibb CO Transaction History
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
- $250 Billion
- Q3 2025
A detailed history of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna holds 20,000 shares of BMY stock, worth $933,000. This represents 0.36% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$933,000
Previous $926 Million
2.57%
% of portfolio
0.36%
Previous 0.37%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.56BCall Options Held
24.3MPut Options Held
25.7M-
Vanguard Group Inc Valley Forge, PA196MShares$9.14 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.51 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.02 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.41 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...